MedTrace Logo

Effectiveness of Advanced Practice Nurse-Led Telehealth on Readmissions

NCT02483494 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2017-08-04

No results posted yet for this study

Summary

Aim. To develop and examine the effectiveness of an APN-led telehealth rehabilitative programme as a transitional nursing therapeutic on readmission rates and health related outcomes amongst patients with Acute Myocardial Infarction (AMI) post discharge.

Design. Randomized controlled trial with repeated measures.

Methodology. A consecutive sampling of 172 patients with AMI will be recruited from a tertiary hospital in Singapore. Participants will be randomised into two groups. The experimental group (ALTRA) will receive APN-led telehealth rehabilitative programme upon discharge in addition to standard care. The control group will receive only standard follow-up care.

Conditions

  • Acute Myocardial Infarction
  • Acute Coronary Syndrome

Interventions

OTHER

APN-led Telemedicine

Allocation to experimental or Usual care is 1:1. The four study APNs will be delivering the care and have at least three years working experiences in coronary care settings. A telephonic script and study protocol is made available to ensure standardization of intervention.

Sponsors & Collaborators

  • National University Hospital, Singapore

    collaborator OTHER

  • National University Heart Centre, Singapore

    lead OTHER

Principal Investigators

  • Karen Koh · National University Heart Centre, Singapore

  • A Mark Richards · National University Heart Centre, Singapore

  • Mark Chan · National University Heart Centre, Singapore

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-08
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02483494 on ClinicalTrials.gov